Pembrolizumab injection is in a class of medications called monoclonal antibodies.
It works by helping your immune system to slow or stop the growth of cancer cells.
Pembrolizumab is a type of immunotherapy.
It is a treatment for a number of different types of cancer such as melanoma.
Find out about how you have it, possible side effects and other important.
Pembrolizumab works by binding to the protein pd-1 on the surface of certain immune cells called t cells, which keeps cancer cells from suppressing the immune system.
Pembrolizumab is a type of targeted therapy that does not directly kill cancer cells but alters a specific cell mechanism that promotes cancer growth and spread.
Pembrolizumab works by stimulating the.
In november 2025, the us fda approved pembrolizumab or pembrolizumab and berahyaluronidase alfa with enfortumab vedotin as neoadjuvant treatment followed by adjuvant treatment after.
On october 16, 2023, the food and drug administration approved pembrolizumab (keytruda, merck) with platinum-containing chemotherapy as neoadjuvant treatment, and with continuation of single.
Learn about keytruda® (pembrolizumab), an immunotherapy that works with your immune system to help fight certain cancers.
Visit the patient website.